Inhaled budesonide for mild COVID-19. Is there more to it than just airways?

Rathi, Sahaj; Ish, Pranav; Kalantri, Ashwini; Kalantri, Shriprakash

Rathi, Sahaj; Ish, Pranav; Kalantri, Ashwini; Kalantri, Shriprakash.

Rathi S; Post Graduate Institute of Medical Education and Research, Chandigarh, India. sahajrathi@gmail.com.
Ish P; Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Kalantri A; Mahatma Gandhi Institue of Medical Sciences, Sevagram, Maharasthra, India.
Kalantri S; Mahatma Gandhi Institue of Medical Sciences, Sevagram, Maharasthra, India.

Adv Respir Med ; 89(5): 552-553, 2021.

Article in English | MEDLINE | ID: covidwho-1478372

Subject(s)

Bronchodilator Agents/therapeutic use; Budesonide/therapeutic use; COVID-19 Drug Treatment; Administration, Inhalation; Humans

Keywords

COVID-19; airways; benefit; budesonide

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Bronchodilator Agents / Budesonide / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Adv Respir Med Year: 2021 Document Type: Article Affiliation country: ARM.a2021.0082

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google